physostigmine has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, RE; Chiang, YH; Glotfelty, EJ; Greig, NH; Hoffer, BJ; Hsueh, SC; Kapogiannis, D; Lecca, D; Nogueras-Ortiz, C; Tweedie, D | 1 |
| Becker, RE; Chiang, YH; Greig, NH; Hoffer, BJ; Hoffer, ME; Pick, CG | 1 |
2 review(s) available for physostigmine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
Topics: Animals; Brain Injuries, Traumatic; Cell Survival; Humans; Mice; Mice, Transgenic; Neuroprotective Agents; Physostigmine; Tartrates; Treatment Outcome | 2020 |
Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Cholinesterase Inhibitors; Drug Repositioning; Humans; Mice; Physostigmine; Psychotropic Drugs; Rats | 2017 |